Literature DB >> 23575081

A retrospective study of incidence of bone metastasis in head and neck cancer.

Virendra Bhandari1, Ravi Kant Jain.   

Abstract

UNLABELLED: The incidence of bone metastasis in head and neck Squamous cell carcinoma is very uncommon. AIM: This retrospective study was done to identify the frequency, clinical presentation, and the clinical course of the metastatic disease to bone from head and neck primary.
MATERIAL AND METHODS: Out of 624 patients of head and neck cancers seen in our clinic 6 patients developed metastasis to solitary or multiple bones during the course of the disease.
RESULTS: Postoperative patients had multiple bone involvement whereas others had solitary bone involvement. Main bones involved were parietal bone of skull, shaft of humerus and femur, sacrum, and ribs. All the patients had survival of few months only after developing metastasis.
CONCLUSION: Improvement in technology has resulted in improved results in advanced head and neck cancer patients; hence measures should be taken for complete responders to diagnose this metastasis early and treat them appropriately.

Entities:  

Mesh:

Year:  2013        PMID: 23575081     DOI: 10.4103/0973-1482.110385

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  10 in total

1.  M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.

Authors:  Lujun Shen; Jun Dong; Sheng Li; Yue Wang; Annan Dong; Wanhong Shu; Ming Wu; Changchuan Pan; Yunfei Xia; Peihong Wu
Journal:  Oncologist       Date:  2015-02-06

Review 2.  HIF targets in bone remodeling and metastatic disease.

Authors:  Rachelle W Johnson; Ernestina Schipani; Amato J Giaccia
Journal:  Pharmacol Ther       Date:  2015-02-12       Impact factor: 12.310

3.  Orthotopic non-metastatic and metastatic oral cancer mouse models.

Authors:  Manish V Bais; Maria Kukuruzinska; Philip C Trackman
Journal:  Oral Oncol       Date:  2015-02-11       Impact factor: 5.337

4.  A Nomogram for Predicting the Risk of Bone Metastasis in Newly Diagnosed Head and Neck Cancer Patients: A Real-World Data Retrospective Cohort Study From SEER Database.

Authors:  Chao Huang; Jialin He; Zichuan Ding; Hao Li; Zongke Zhou; Xiaojun Shi
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

5.  Incidence of bone metastasis in carcinoma buccal mucosa.

Authors:  Virendra Bhandari
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Apr-Jun

6.  Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events.

Authors:  Salvatore Grisanti; Susanna Bianchi; Laura D Locati; Luca Triggiani; Stefania Vecchio; Alberto Bonetta; Cristiana Bergamini; Pierfranco Conte; Mario Airoldi; Marco Merlano; Paolo Carlini; Toni Ibrahim; Ciro Rossetto; Salvatore Alfieri; Paolo Pronzato; Sandro Tonoli; Roberto Maroldi; Piero Nicolai; Carlo Resteghini; Stefano M Magrini; Alfredo Berruti
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

7.  Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.

Authors:  Xue-Song Sun; Yu-Jing Liang; Sai-Lan Liu; Qiu-Yan Chen; Shan-Shan Guo; Yue-Feng Wen; Li-Ting Liu; Hao-Jun Xie; Qing-Nan Tang; Xiao-Yun Li; Jin-Jie Yan; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Cancer Res Treat       Date:  2019-01-04       Impact factor: 4.679

8.  The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis.

Authors:  Changxing Chi; Zhiyi Fan; Binbin Yang; He Sun; Zengpai Zheng
Journal:  J Oncol       Date:  2021-09-27       Impact factor: 4.375

Review 9.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Authors:  Suwen Bai; Zunyun Wang; Minghua Wang; Junai Li; Yuan Wei; Ruihuan Xu; Juan Du
Journal:  Front Cell Dev Biol       Date:  2022-03-02

10.  Female sex is associated with a lower risk of bone metastases and favourable prognosis in non-sex-specific cancers.

Authors:  Wenjuan Ma; Karl Peltzer; Lisha Qi; Guijun Xu; Zheng Liu; Jingyi Wang; Min Mao; Vladimir P Chekhonin; Xin Wang; Chao Zhang
Journal:  BMC Cancer       Date:  2019-10-25       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.